ARCHIVES

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Ethics Commission To Take Up Again Compensation Issue

September 11, 1981

Advisors Discuss NCI Intramural Program In Closed Session, Defend Process

December 16, 1994

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993

Roswell Park Wins Grants For Young Investigators.

January 11, 2002

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

February 19, 2010

Community Oncology Program Proves Technology Transfer Can Work; Survival Improvement Shown

March 21, 1980